General Biologicals Corporation
General Biologicals Corporation (GBC), founded in 1984, is a developer and manufacturer of diagnostics and pharmaceutical. We develop high quality in-vitro diagnostics for doctors to make clinical decisions in the area of hepatitis, tumor markers, retro virus, fertility, Thyroid, and Steroids. In general consumable applications, we provide an anti-bacterial peptide in areas of pharmaceutical, cosmetics, and oral products.
Microbiology Product Areas
Clinical | ||
| A COVID-19 qPCR Kits | Show all suppliers | |
| A COVID-19 Antigen Test | Show all suppliers | |
| A COVID-19 IgG/IgM | Show all suppliers | |
| ELISA | Show all suppliers | |
Get our eNewsletter
Get the latest microbiology news every week - straight to your inbox!
LATEST MICROBIOLOGY NEWS
- Seasonal Flu and Coronavirus Identification
- Is it Flu or is it COVID-19? Test With a Swab From Puritan to Be Sure
- Influenza Virus Research Tools
- Novel Molecular Transport Media for Dual COVID-19 and Influenza Sampling
- Thaw Samples 60% Faster with SPL Guard Florida
- New Reader Quantifies the Level of Viral Load in COVID-19 Infected Patients
- FDA Clears Antimicrobial Susceptibility Test for P. aeruginosa
- Asymptomatic People Need to be Tested for COVID-19 says CDC
- Limit of Detection Data Released for FDA-EUA COVID-19 qPCR Kits
- Is It Bacterial or Viral? - Triage Assay Tested on COVID-19 Symptomatic Patients
MICROBIOLOGY EVENTS
- A Boehringer Ingelheim Business Case: Automating Endotoxin Water Testing
- Solutions for Dairy Antibiotics from Your Trusted Testing Partner
- Hot Topics in Food Microbiology: On-Line Event
- RSSL Training: QP Module - Pharmaceutical Microbiology
- Pharmaceutical Water Systems: Principles in Practice® - Barnard Castle, UK
- Forum Labo - Lyon - NEW DATES
- Climate Change Impact on Emerging Risks in the Food Chain - EFSA Virtual Meeting
- Pre-Analytical Scientific Webinars 2020: Harmonisation of Pre-Analytical Phase and Role of EFLM
- Current Requirements for Cleaning Validation
- New Medical Device Regulation (MDR) 2017/745